Meet Wendy Winckler, Executive Director of Oncology Research at Novartis.

AI is already accelerating drug discovery and health delivery. It has great potential to accelerate research, workflow and processes, and even reengineer entire healthcare systems. But what challenges must be addressed first? Shahram Ebadollahi and Ann Aerts share the ideas they discussed at the Intelligent Health summit in Basel this week.

In Guatemala, social worker Eduardo Canuz fights logistical and cultural challenges while preventing women and infants from inhaling smoke.

While the country has made great strides in controlling AIDS and other infectious diseases, Kenyans are living longer and chronic diseases such as diabetes, heart disease and cancer are on the rise.

Novartis and Sangamo Therapeutics plan to pursue potential treatments for neurodevelopmental diseases.

For all too many people living with heart failure, hospitalizations are a recurring part of life, affecting the lives of both patients and their caregivers.

Dr. Botond Roska says we should keep our eyes on gene therapy.

Two scientists from Basel are trying to shed light on why myopia is impacting more and more people.

A Novartis experimental drug in clinical trial aims to block liver cancer growth